UB Paderborn / Katalog / Suche / in CDI

P1380: DEGREE OF CELL PACKING OF CRYOPRESERVED AT ‐80ºC HEMATOPOIETIC STEM CELLS DOES NOT AFFECT THEIR VIABILITY AND HEMATOLOGIC RECOVERY OF TRANSPLANTED MYELOMA PATIENTS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1264-1265

2022

Volltextzugriff (PDF)

PB2175: TRYPAN BLUE AND FLOW CYTOMETRY CELL VIABILITY TESTING OF PACKED OR DILUTED CRYOPRESERVED AT ‐80ºC HEMATOPOIETIC STEM CELLS SHOW SIMILAR RESULTS

HemaSphere, 2022-06, Vol.6 (Suppl), p.2045-2046

2022

Volltextzugriff (PDF)

PB2195: MOBILIZATION WITH CYTARABINE AND GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) GIVES BETTER YIELD THAN MOBILIZATION WITH G-CSF ALONE OR COMBINED WITH CYCLOPHOSPHAMIDE

HemaSphere, 2022-06, Vol.6 (Suppl), p.2065-2066

2022

Volltextzugriff (PDF)

Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?

Journal of B.U. ON., 2009-09, Vol.14 Suppl 1, p.S89

Mincheff, M

2009

Volltextzugriff (PDF)

Changes in Donor Leukocytes during Blood Storage. Implications on Post- Transfusion Immunomodulation and Transfusion-Associated GVHD

Vox sanguinis, 1998-06, Vol.74 (S2), p.189-200

Mincheff, M.

1998

Volltextzugriff (PDF)

Immune responses against PSMA after gene-based vaccination for immunotherapy - A: results from immunizations in animals

Cancer gene therapy, 2006-04, Vol.13 (4), p.436-444

2006

Volltextzugriff (PDF)

Biochemical Nature and Mapping of PSMA Epitopes Recognized by Human Antibodies Induced after Immunization with Gene-based Vaccines

Anticancer research, 2005-11, Vol.25 (6C), p.4727-4732

2005

Volltextzugriff (PDF)

PB2195: MOBILIZATION WITH CYTARABINE AND GRANULOCYTE COLONY STIMULATING FACTOR (G‐CSF) GIVES BETTER YIELD THAN MOBILIZATION WITH G‐CSF ALONE OR COMBINED WITH CYCLOPHOSPHAMIDE

HemaSphere, 2022-06, Vol.6, p.2065-2066

2022

Volltextzugriff (PDF)

Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial

European urology, 2000-08, Vol.38 (2), p.208-217

2000

Volltextzugriff (PDF)

In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer—changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-γ lymphokine profile

Critical reviews in oncology/hematology, 2001-07, Vol.39 (1), p.125-132

2001

Volltextzugriff (PDF)

Tularemia outbreak, Bulgaria, 1997-2005

Emerging infectious diseases, 2006-04, Vol.12 (4), p.678-680

2006

Volltextzugriff (PDF)

Blood Transfusion and Immunomodulation: A Possible Mechanism

Vox sanguinis, 1993-01, Vol.65 (1), p.18-24

1993

Volltextzugriff (PDF)

PB2365 CELL DOSE AND HEMATOLOGIC RECOVERY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA

HemaSphere, 2019-06, Vol.3 (S1), p.1053-n/a

2019

Volltextzugriff (PDF)

PF779 VIABILITY OF HEMATOPOETIC STEM CELLS FOLLOWING STORAGE AT −80OC WITH 5% DIMETHYLSULFOXIDE AND HEMATOLOGIC RECOVERY IN TRANSPLANTED MYELOMA PATIENTS

HemaSphere, 2019-06, Vol.3 (S1), p.343-344

2019

Volltextzugriff (PDF)

Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model

Transplantation, 1995-10, Vol.60 (8), p.815

1995

Volltextzugriff (PDF)

Costimulatory signals necessary for induction of T cell proliferation

Transplantation, 1990-04, Vol.49 (4), p.768

1990

Volltextzugriff (PDF)

Blood Transfusion, Blood Storage and Immunomodulation

Immunological investigations, 1995, Vol.24 (1-2), p.303-309

1995

Volltextzugriff (PDF)

Apoptosis, transforming growth factor-β, and the immunosuppressive effect of transfusion

Transfusion (Philadelphia, Pa.), 2002-09, Vol.42 (9), p.1221-1223

2002

Volltextzugriff (PDF)

Induction of primary mixed leukocyte reactions with ultraviolet B or chemically modified stimulator cells

Transplantation, 1989-12, Vol.48 (6), p.1052

1989

Volltextzugriff (PDF)

Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes

Cancer gene therapy, 2003-12, Vol.10 (12), p.907-917

2003

Volltextzugriff (PDF)

Depletion of CD25 cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein

Cancer gene therapy, 2005-02, Vol.12 (2), p.185-197

2005

Volltextzugriff (PDF)

An Alternative Mechanism for the Immunosuppressive Effect of Transfusion

Vox sanguinis, 2002-08, Vol.83 (s1), p.417-420

2002

Volltextzugriff (PDF)

Depletion of CD25 super(+) cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein

Cancer gene therapy, 2005-02, Vol.12 (2), p.185-197

2005

Volltextzugriff (PDF)

Fas and Fas Ligand Expression on Human Peripheral Blood Leukocytes

Vox sanguinis, 1998-02, Vol.74 (2), p.113-121

1998

Volltextzugriff (PDF)

Gene-based vaccines for immunotherapy (IT) of prostate cancer following radical prostatectomy — A 5-year experience from a clinical trial

European urology supplements : official journal of the European Association of Urology, 2003, Vol.2 (6), p.18-18

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

P1380: DEGREE OF CELL PACKING OF CRYOPRESERVED AT ‐80ºC HEMATOPOIETIC STEM CELLS DOES NOT AFFECT THEIR VIABILITY AND HEMATOLOGIC RECOVERY OF TRANSPLANTED MYELOMA PATIENTS

PB2175: TRYPAN BLUE AND FLOW CYTOMETRY CELL VIABILITY TESTING OF PACKED OR DILUTED CRYOPRESERVED AT ‐80ºC HEMATOPOIETIC STEM CELLS SHOW SIMILAR RESULTS

PB2195: MOBILIZATION WITH CYTARABINE AND GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) GIVES BETTER YIELD THAN MOBILIZATION WITH G-CSF ALONE OR COMBINED WITH CYCLOPHOSPHAMIDE

Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?

Changes in Donor Leukocytes during Blood Storage. Implications on Post- Transfusion Immunomodulation and Transfusion-Associated GVHD

Immune responses against PSMA after gene-based vaccination for immunotherapy - A: results from immunizations in animals

Biochemical Nature and Mapping of PSMA Epitopes Recognized by Human Antibodies Induced after Immunization with Gene-based Vaccines

PB2195: MOBILIZATION WITH CYTARABINE AND GRANULOCYTE COLONY STIMULATING FACTOR (G‐CSF) GIVES BETTER YIELD THAN MOBILIZATION WITH G‐CSF ALONE OR COMBINED WITH CYCLOPHOSPHAMIDE

Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial

In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer—changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-γ lymphokine profile

Tularemia outbreak, Bulgaria, 1997-2005

Blood Transfusion and Immunomodulation: A Possible Mechanism

PB2365 CELL DOSE AND HEMATOLOGIC RECOVERY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA

PF779 VIABILITY OF HEMATOPOETIC STEM CELLS FOLLOWING STORAGE AT −80OC WITH 5% DIMETHYLSULFOXIDE AND HEMATOLOGIC RECOVERY IN TRANSPLANTED MYELOMA PATIENTS

Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model

Costimulatory signals necessary for induction of T cell proliferation

Blood Transfusion, Blood Storage and Immunomodulation

Apoptosis, transforming growth factor-β, and the immunosuppressive effect of transfusion

Induction of primary mixed leukocyte reactions with ultraviolet B or chemically modified stimulator cells

Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes

Depletion of CD25 cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein

An Alternative Mechanism for the Immunosuppressive Effect of Transfusion

Depletion of CD25 super(+) cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein

Fas and Fas Ligand Expression on Human Peripheral Blood Leukocytes

Gene-based vaccines for immunotherapy (IT) of prostate cancer following radical prostatectomy — A 5-year experience from a clinical trial

Suchergebnisse filtern